Shuster: Robinson Pharma GMP Compliant
January 8, 2008
SANTA ANA, Calif.Shuster Labs completed an audit of Robinson Pharmas (RPI) dietary supplement manufacturing facility and confirmed RPIs conformance with cGMPs (current good manufacturing practices). Shusters audit covered all aspects of the manufacturing process, including standard operating procedures (SOPs), staff qualifications, training, cleanliness, and the full manufacturing process. RPI was also recently granted a drug manufacturing license by the state of California.
Kenn Israel, RPI's vice president of marketing, said: The Shuster certification, as well as the drug manufacturing license, will allow RPI to pursue important additional market opportunities in 2008. As we gain additional international and domestic clients, certification from Shuster reinforces our quality message. The certification of cGMP compliance compliments our industry-leading capacity as the largest soft gel encapsulator in North America and our ability to rapidly complete manufacturing and turn around orders.
You May Also Like